Veham-Sandoz en es it fr

Veham-Sandoz Brand names, Veham-Sandoz Analogs

Veham-Sandoz Brand Names Mixture

  • No information avaliable

Veham-Sandoz Chemical_Formula

C32H32O13S

Veham-Sandoz RX_link

http://www.rxlist.com/cgi/generic2/teniposide.htm

Veham-Sandoz fda sheet

http://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=110

Veham-Sandoz msds (material safety sheet)

Veham-Sandoz Synthesis Reference

No information avaliable

Veham-Sandoz Molecular Weight

656.655 g/mol

Veham-Sandoz Melting Point

No information avaliable

Veham-Sandoz H2O Solubility

No information avaliable

Veham-Sandoz State

Solid

Veham-Sandoz LogP

1.963

Veham-Sandoz Dosage Forms

Liquid

Veham-Sandoz Indication

Treatment of refractory acute lymphoblastic leukaemia

Veham-Sandoz Pharmacology

Teniposide is a phase-specific cytotoxic drug, acting in the late S or early G 2 phase of the cell cycle, thus preventing cells from entering mitosis. Teniposide causes dose-dependent single- and double-stranded breaks in DNA and DNA: protein cross-links. The mechanism of action appears to be related to the inhibition of type II topoisomerase activity since teniposide does not intercalate into DNA or bind strongly to DNA.

Veham-Sandoz Absorption

No information avaliable

Veham-Sandoz side effects and Toxicity

No information avaliable

Veham-Sandoz Patient Information

No information avaliable

Veham-Sandoz Organisms Affected

Humans and other mammals